_id
690daf67ccc777a4e85d0b00
Ticker
AONC
Name
American Oncology Network Inc.
Exchange
NASDAQ
Address
14543 Global Parkway, Fort Myers, FL, United States, 33913
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.aoncology.com
Description
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Last Close
11.75
Volume
-
Current Price
11.75
Change
-0.25
Last Updated
2026-01-20T15:28:17.760Z
Image
data:image/webp;base64,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
Ipo Date
2021-05-05T00:00:00.000Z
Market Cap
343668256
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
-
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2024-12-31
Revenue
490884000
Cost Of Revenue
448355000
Gross Profit
42529000
Operating Expenses
34312000
Operating Income
8217000
Interest Expense
1587000
Pretax Income
2333000
Net Income
1316000
Eps
0.09754651248980802
Dividends Per Share
-
Shares Outstanding
29248362
Income Tax Expense
-72000
EBITDA
9442000
Operating Margin
1.6739188891876695
Total Other Income Expense Net
-5884000
Cash
62849000
Short Term Investments
9791000
Receivables
189626000
Inventories
60712000
Total Current Assets
331472000
Property Plant Equipment
98531000
Total Assets
470328000
Payables
170736000
Short Term Debt
12226000
Long Term Debt
87123000
Total Liabilities
362321000
Equity
18771000
Bs_currency_symbol
USD
Depreciation
5522000
Change In Working Capital
-2738000
Cash From Operations
11926000
Capital Expenditures
6326000
Cash From Investing
-17220000
Cash From Financing
48711000
Net Change In Cash
43417000
Cf_currency_symbol
USD
PE
-
PB
8.444901710084705
ROE
7.010814554365777
ROA
0.2798047320168053
FCF
5600000
Fcf Percent
0.011407990482476512
Piotroski FScore
4
Health Score
30
Deep Value Investing Score
6.5
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
4.5
Value Investing Score
5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
490884000
Quarters > 0 > income Statement > cost Of Revenue
448355000
Quarters > 0 > income Statement > gross Profit
42529000
Quarters > 0 > income Statement > operating Expenses
34312000
Quarters > 0 > income Statement > operating Income
8217000
Quarters > 0 > income Statement > interest Expense
1587000
Quarters > 0 > income Statement > pretax Income
2333000
Quarters > 0 > income Statement > net Income
1316000
Quarters > 0 > income Statement > eps
0.09754651248980802
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13491000
Quarters > 0 > income Statement > income Tax Expense
-72000
Quarters > 0 > income Statement > EBITDA
9442000
Quarters > 0 > income Statement > operating Margin
1.6739188891876695
Quarters > 0 > income Statement > total Other Income Expense Net
-5884000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
62849000
Quarters > 0 > balance Sheet > short Term Investments
9791000
Quarters > 0 > balance Sheet > receivables
189626000
Quarters > 0 > balance Sheet > inventories
60712000
Quarters > 0 > balance Sheet > total Current Assets
331472000
Quarters > 0 > balance Sheet > property Plant Equipment
98531000
Quarters > 0 > balance Sheet > total Assets
470328000
Quarters > 0 > balance Sheet > payables
170736000
Quarters > 0 > balance Sheet > short Term Debt
12226000
Quarters > 0 > balance Sheet > long Term Debt
87123000
Quarters > 0 > balance Sheet > total Liabilities
362321000
Quarters > 0 > balance Sheet > equity
18771000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
2405000
Quarters > 0 > cash Flow > depreciation
5522000
Quarters > 0 > cash Flow > change In Working Capital
-2738000
Quarters > 0 > cash Flow > cash From Operations
11926000
Quarters > 0 > cash Flow > capital Expenditures
6326000
Quarters > 0 > cash Flow > cash From Investing
-17220000
Quarters > 0 > cash Flow > cash From Financing
48711000
Quarters > 0 > cash Flow > net Change In Cash
43417000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.09754651248980802
Quarters > 0 > ratios > PB
8.444901710084705
Quarters > 0 > ratios > ROE
7.010814554365777
Quarters > 0 > ratios > ROA
0.2798047320168053
Quarters > 0 > ratios > FCF
5600000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.011407990482476512
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
470279000
Quarters > 1 > income Statement > cost Of Revenue
433746000
Quarters > 1 > income Statement > gross Profit
36533000
Quarters > 1 > income Statement > operating Expenses
34932000
Quarters > 1 > income Statement > operating Income
1601000
Quarters > 1 > income Statement > interest Expense
1874000
Quarters > 1 > income Statement > pretax Income
-1560000
Quarters > 1 > income Statement > net Income
-1069000
Quarters > 1 > income Statement > eps
-0.0805940892641737
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13264000
Quarters > 1 > income Statement > income Tax Expense
-283000
Quarters > 1 > income Statement > EBITDA
4943000
Quarters > 1 > income Statement > operating Margin
0.34043620914393374
Quarters > 1 > income Statement > total Other Income Expense Net
-3161000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
19432000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
193144000
Quarters > 1 > balance Sheet > inventories
49266000
Quarters > 1 > balance Sheet > total Current Assets
271230000
Quarters > 1 > balance Sheet > property Plant Equipment
91015000
Quarters > 1 > balance Sheet > total Assets
394811000
Quarters > 1 > balance Sheet > payables
155494000
Quarters > 1 > balance Sheet > short Term Debt
12388000
Quarters > 1 > balance Sheet > long Term Debt
87633000
Quarters > 1 > balance Sheet > total Liabilities
340722000
Quarters > 1 > balance Sheet > equity
-38840000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1069000
Quarters > 1 > cash Flow > depreciation
4629000
Quarters > 1 > cash Flow > change In Working Capital
-35993000
Quarters > 1 > cash Flow > cash From Operations
-28079000
Quarters > 1 > cash Flow > capital Expenditures
6452000
Quarters > 1 > cash Flow > cash From Investing
15000000
Quarters > 1 > cash Flow > cash From Financing
-1307000
Quarters > 1 > cash Flow > net Change In Cash
-14386000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.0805940892641737
Quarters > 1 > ratios > PB
-4.012667353244079
Quarters > 1 > ratios > ROE
2.752317198764161
Quarters > 1 > ratios > ROA
-0.27076246609137034
Quarters > 1 > ratios > FCF
-34531000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.0734266254712628
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
433982000
Quarters > 2 > income Statement > cost Of Revenue
404589000
Quarters > 2 > income Statement > gross Profit
29393000
Quarters > 2 > income Statement > operating Expenses
37402000
Quarters > 2 > income Statement > operating Income
-8009000
Quarters > 2 > income Statement > interest Expense
1833000
Quarters > 2 > income Statement > pretax Income
-3449000
Quarters > 2 > income Statement > net Income
3621000
Quarters > 2 > income Statement > eps
0.34830704116968064
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10396000
Quarters > 2 > income Statement > income Tax Expense
-324000
Quarters > 2 > income Statement > EBITDA
3237000
Quarters > 2 > income Statement > operating Margin
-1.8454682452267606
Quarters > 2 > income Statement > total Other Income Expense Net
4560000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
33818000
Quarters > 2 > balance Sheet > short Term Investments
21391000
Quarters > 2 > balance Sheet > receivables
188523000
Quarters > 2 > balance Sheet > inventories
54280000
Quarters > 2 > balance Sheet > total Current Assets
306262000
Quarters > 2 > balance Sheet > property Plant Equipment
93119000
Quarters > 2 > balance Sheet > total Assets
430762000
Quarters > 2 > balance Sheet > payables
189483000
Quarters > 2 > balance Sheet > short Term Debt
12512000
Quarters > 2 > balance Sheet > long Term Debt
88241000
Quarters > 2 > balance Sheet > total Liabilities
376911000
Quarters > 2 > balance Sheet > equity
25002000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-24961000
Quarters > 2 > cash Flow > depreciation
4674000
Quarters > 2 > cash Flow > change In Working Capital
-35253000
Quarters > 2 > cash Flow > cash From Operations
45137000
Quarters > 2 > cash Flow > capital Expenditures
4132000
Quarters > 2 > cash Flow > cash From Investing
1522000
Quarters > 2 > cash Flow > cash From Financing
-254000
Quarters > 2 > cash Flow > net Change In Cash
46405000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.34830704116968064
Quarters > 2 > ratios > PB
4.885729141668667
Quarters > 2 > ratios > ROE
14.482841372690187
Quarters > 2 > ratios > ROA
0.8406033958427159
Quarters > 2 > ratios > FCF
41005000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.09448548557313437
Quarters > 2 > health Score
48
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
364339000
Quarters > 3 > income Statement > cost Of Revenue
354948000
Quarters > 3 > income Statement > gross Profit
9391000
Quarters > 3 > income Statement > operating Expenses
28629000
Quarters > 3 > income Statement > operating Income
-19238000
Quarters > 3 > income Statement > interest Expense
1763000
Quarters > 3 > income Statement > pretax Income
-22116000
Quarters > 3 > income Statement > net Income
-7841000
Quarters > 3 > income Statement > eps
-1.0415781083953242
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7528000
Quarters > 3 > income Statement > income Tax Expense
2894000
Quarters > 3 > income Statement > EBITDA
-15807000
Quarters > 3 > income Statement > operating Margin
-5.280247242266131
Quarters > 3 > income Statement > total Other Income Expense Net
-2878000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
74944000
Quarters > 3 > balance Sheet > short Term Investments
30105000
Quarters > 3 > balance Sheet > receivables
169597000
Quarters > 3 > balance Sheet > inventories
44288000
Quarters > 3 > balance Sheet > total Current Assets
323963000
Quarters > 3 > balance Sheet > property Plant Equipment
84355000
Quarters > 3 > balance Sheet > total Assets
421921000
Quarters > 3 > balance Sheet > payables
188329000
Quarters > 3 > balance Sheet > short Term Debt
15840000
Quarters > 3 > balance Sheet > long Term Debt
80856000
Quarters > 3 > balance Sheet > total Liabilities
365813000
Quarters > 3 > balance Sheet > equity
-102460000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-24961000
Quarters > 3 > cash Flow > depreciation
4546000
Quarters > 3 > cash Flow > change In Working Capital
53616000
Quarters > 3 > cash Flow > cash From Operations
45137000
Quarters > 3 > cash Flow > capital Expenditures
4132000
Quarters > 3 > cash Flow > cash From Investing
1522000
Quarters > 3 > cash Flow > cash From Financing
-254000
Quarters > 3 > cash Flow > net Change In Cash
46405000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.0415781083953242
Quarters > 3 > ratios > PB
-0.863302752293578
Quarters > 3 > ratios > ROE
7.652742533671677
Quarters > 3 > ratios > ROA
-1.858404772457403
Quarters > 3 > ratios > FCF
41005000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.11254628244574422
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1759484000
Annuals > 0 > income Statement > cost Of Revenue
1641638000
Annuals > 0 > income Statement > gross Profit
117846000
Annuals > 0 > income Statement > operating Expenses
135275000
Annuals > 0 > income Statement > operating Income
-17429000
Annuals > 0 > income Statement > interest Expense
7057000
Annuals > 0 > income Statement > pretax Income
-24460000
Annuals > 0 > income Statement > net Income
-3973000
Annuals > 0 > income Statement > eps
-0.2944926247127715
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13491000
Annuals > 0 > income Statement > income Tax Expense
2498000
Annuals > 0 > income Statement > EBITDA
1815000
Annuals > 0 > income Statement > operating Margin
-0.9905745093447852
Annuals > 0 > income Statement > total Other Income Expense Net
10404000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
62849000
Annuals > 0 > balance Sheet > short Term Investments
9791000
Annuals > 0 > balance Sheet > receivables
189626000
Annuals > 0 > balance Sheet > inventories
60712000
Annuals > 0 > balance Sheet > total Current Assets
331472000
Annuals > 0 > balance Sheet > property Plant Equipment
98531000
Annuals > 0 > balance Sheet > total Assets
470328000
Annuals > 0 > balance Sheet > payables
170736000
Annuals > 0 > balance Sheet > short Term Debt
12226000
Annuals > 0 > balance Sheet > long Term Debt
87123000
Annuals > 0 > balance Sheet > total Liabilities
362321000
Annuals > 0 > balance Sheet > equity
18771000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-26958000
Annuals > 0 > cash Flow > depreciation
19371000
Annuals > 0 > cash Flow > change In Working Capital
-20368000
Annuals > 0 > cash Flow > cash From Operations
-4943000
Annuals > 0 > cash Flow > capital Expenditures
20954000
Annuals > 0 > cash Flow > cash From Investing
-2411000
Annuals > 0 > cash Flow > cash From Financing
41664000
Annuals > 0 > cash Flow > net Change In Cash
34310000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.2944926247127715
Annuals > 0 > ratios > PB
8.444901710084705
Annuals > 0 > ratios > ROE
-21.16562783016355
Annuals > 0 > ratios > ROA
-0.8447296354884251
Annuals > 0 > ratios > FCF
-25897000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.014718519747835161
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1279185000
Annuals > 1 > income Statement > cost Of Revenue
1196389000
Annuals > 1 > income Statement > gross Profit
82796000
Annuals > 1 > income Statement > operating Expenses
131950000
Annuals > 1 > income Statement > operating Income
-49154000
Annuals > 1 > income Statement > interest Expense
6417000
Annuals > 1 > income Statement > pretax Income
-62507000
Annuals > 1 > income Statement > net Income
-5542000
Annuals > 1 > income Statement > eps
-0.8288962010170505
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6686000
Annuals > 1 > income Statement > income Tax Expense
384000
Annuals > 1 > income Statement > EBITDA
-39351000
Annuals > 1 > income Statement > operating Margin
-3.8426029073198955
Annuals > 1 > income Statement > total Other Income Expense Net
-13353000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
28539000
Annuals > 1 > balance Sheet > short Term Investments
35389000
Annuals > 1 > balance Sheet > receivables
165029000
Annuals > 1 > balance Sheet > inventories
44569000
Annuals > 1 > balance Sheet > total Current Assets
277803000
Annuals > 1 > balance Sheet > property Plant Equipment
83788000
Annuals > 1 > balance Sheet > total Assets
374453000
Annuals > 1 > balance Sheet > payables
127645000
Annuals > 1 > balance Sheet > short Term Debt
15762000
Annuals > 1 > balance Sheet > long Term Debt
80641000
Annuals > 1 > balance Sheet > total Liabilities
303740000
Annuals > 1 > balance Sheet > equity
-161727000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-63150000
Annuals > 1 > cash Flow > depreciation
16739000
Annuals > 1 > cash Flow > change In Working Capital
12074000
Annuals > 1 > cash Flow > cash From Operations
-18118000
Annuals > 1 > cash Flow > capital Expenditures
12283000
Annuals > 1 > cash Flow > cash From Investing
-35400000
Annuals > 1 > cash Flow > cash From Financing
55131000
Annuals > 1 > cash Flow > net Change In Cash
1613000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.8288962010170505
Annuals > 1 > ratios > PB
-0.48575995350188894
Annuals > 1 > ratios > ROE
3.42676238352285
Annuals > 1 > ratios > ROA
-1.4800255305739305
Annuals > 1 > ratios > FCF
-30401000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.023765913452706216
Annuals > 1 > health Score
17
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1149670000
Annuals > 2 > income Statement > cost Of Revenue
1054217000
Annuals > 2 > income Statement > gross Profit
95453000
Annuals > 2 > income Statement > operating Expenses
89887000
Annuals > 2 > income Statement > operating Income
5566000
Annuals > 2 > income Statement > interest Expense
3417000
Annuals > 2 > income Statement > pretax Income
2589000
Annuals > 2 > income Statement > net Income
2589000
Annuals > 2 > income Statement > eps
0.0621042026482441
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41688000
Annuals > 2 > income Statement > income Tax Expense
1026636000
Annuals > 2 > income Statement > EBITDA
23089000
Annuals > 2 > income Statement > operating Margin
0.48413892682247944
Annuals > 2 > income Statement > total Other Income Expense Net
-2977000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
26926000
Annuals > 2 > balance Sheet > short Term Investments
9851000
Annuals > 2 > balance Sheet > receivables
166096000
Annuals > 2 > balance Sheet > inventories
36476000
Annuals > 2 > balance Sheet > total Current Assets
242019000
Annuals > 2 > balance Sheet > property Plant Equipment
75704000
Annuals > 2 > balance Sheet > total Assets
326228000
Annuals > 2 > balance Sheet > payables
106495000
Annuals > 2 > balance Sheet > short Term Debt
19204000
Annuals > 2 > balance Sheet > long Term Debt
80301000
Annuals > 2 > balance Sheet > total Liabilities
264212000
Annuals > 2 > balance Sheet > equity
62016000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
2589000
Annuals > 2 > cash Flow > depreciation
17083000
Annuals > 2 > cash Flow > change In Working Capital
-26962000
Annuals > 2 > cash Flow > cash From Operations
-6784000
Annuals > 2 > cash Flow > capital Expenditures
7193000
Annuals > 2 > cash Flow > cash From Investing
-13991000
Annuals > 2 > cash Flow > cash From Financing
15347000
Annuals > 2 > cash Flow > net Change In Cash
-5428000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.0621042026482441
Annuals > 2 > ratios > PB
7.898510061919505
Annuals > 2 > ratios > ROE
4.174729102167183
Annuals > 2 > ratios > ROA
0.7936167343085203
Annuals > 2 > ratios > FCF
-13977000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.012157401689180374
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
943747000
Annuals > 3 > income Statement > cost Of Revenue
865788000
Annuals > 3 > income Statement > gross Profit
77959000
Annuals > 3 > income Statement > operating Expenses
77048000
Annuals > 3 > income Statement > operating Income
911000
Annuals > 3 > income Statement > interest Expense
1419000
Annuals > 3 > income Statement > pretax Income
355000
Annuals > 3 > income Statement > net Income
-105000
Annuals > 3 > income Statement > eps
-0.002518710420264824
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41688000
Annuals > 3 > income Statement > income Tax Expense
460000
Annuals > 3 > income Statement > EBITDA
7853000
Annuals > 3 > income Statement > operating Margin
0.0965301081751783
Annuals > 3 > income Statement > total Other Income Expense Net
-556000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
27354000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
138116000
Annuals > 3 > balance Sheet > inventories
34529000
Annuals > 3 > balance Sheet > total Current Assets
208276000
Annuals > 3 > balance Sheet > property Plant Equipment
32648000
Annuals > 3 > balance Sheet > total Assets
248298000
Annuals > 3 > balance Sheet > payables
92908000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
63694000
Annuals > 3 > balance Sheet > total Liabilities
22256543
Annuals > 3 > balance Sheet > equity
312622467
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-105000
Annuals > 3 > cash Flow > depreciation
6079000
Annuals > 3 > cash Flow > change In Working Capital
-34775000
Annuals > 3 > cash Flow > cash From Operations
-1230297
Annuals > 3 > cash Flow > capital Expenditures
8322000
Annuals > 3 > cash Flow > cash From Investing
-333500000
Annuals > 3 > cash Flow > cash From Financing
335533606
Annuals > 3 > cash Flow > net Change In Cash
803309
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.002518710420264824
Annuals > 3 > ratios > PB
1.5668547583945718
Annuals > 3 > ratios > ROE
-0.0335868375064675
Annuals > 3 > ratios > ROA
-0.04228789599594036
Annuals > 3 > ratios > FCF
-9552297
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.010121671380147433
Annuals > 3 > health Score
35
Valuation > metrics > PE
0.09754651248980802
Valuation > metrics > PB
8.444901710084705
Valuation > final Score
40
Valuation > verdict
41.2% Overvalued
Profitability > metrics > ROE
7.010814554365777
Profitability > metrics > ROA
0.39701694260752035
Profitability > metrics > Net Margin
0.0026808777633819804
Profitability > final Score
16
Profitability > verdict
Weak
Risk > metrics > Debt Equity
19.302168238239837
Risk > metrics > Interest Coverage
5.177693761814745
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.8116986040817218
Liquidity > metrics > Quick Ratio
1.4798701369683323
Liquidity > final Score
95
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
51.142708583313336
Prev Valuations > 2
50
Prev Profitabilities > 0
6
Prev Profitabilities > 1
34
Prev Profitabilities > 2
15
Prev Risks > 0
33
Prev Risks > 1
-11
Prev Risks > 2
-14
Prev Liquidities > 0
90
Prev Liquidities > 1
88
Prev Liquidities > 2
90
Updated At
2026-01-20T21:23:38.986Z
Earnings History > 0 > period
2024-12-31
Earnings History > 0 > report Date
2025-03-27
Earnings History > 0 > date
2024-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-03-31
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-1.2223
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2023-12-31
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.7643
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-09-30
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.6069
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-06-30
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1681
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-03-31
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0113
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-12-31
Earnings History > 6 > report Date
2023-03-31
Earnings History > 6 > date
2022-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.04
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-14
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.08
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-08-12
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.04
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.04
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-04-13
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.04
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.04
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-12-31
Earnings History > 10 > report Date
2021-12-31
Earnings History > 10 > date
2021-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0136
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-09-30
Earnings History > 11 > report Date
2021-11-22
Earnings History > 11 > date
2021-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.08
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.08
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-06-30
Earnings History > 12 > report Date
2021-08-24
Earnings History > 12 > date
2021-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.15
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.15
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-05-27
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGenesis Cancer and Blood Institute and American Oncology Network Welcome Endocrinologist Dr. Daryl Burrows and Nurse Practitioner Natalie Brown, APRN markets.businessinsider.com
Read more →3 Days/Wk, Expanding to 4 in Jan — Dr. Chitra Rajagopal Joins American Oncology Network's CCBD Team Stock Titan
Read more →Showing 2 of 9
(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of American Oncology Network Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-12-31
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.